Dear Healthcare Provider,
Level 1 Diagnostics is designed to help healthcare providers diagnose and treat cardiovascular disease in their patients.
Cardiovascular disease is the number one killer in the U.S. and early detection and prevention is the key to cardiovascular health. Over 50% of American men and women who experience a heart attack have no prior knowledge or symptoms of their heart disease and almost 50% of first time heart attack patients do not survive the event.
Currently, providers offices may perform screening tests, but the screenings are not as comprehensive or predictive as Level 1 Diagnostics testing. The Level 1 Diagnostics program includes the world’s foremost medical devices in detecting early cardiovascular disease, which has made Level 1 Diagnostics testing the gold standard. The program consists of simple, technologically- advanced noninvasive tests. Sometimes the tests uncover serious heart disease, in which case, those patients are immediately referred for further testing or treatment.
Guidelines for Testing
The published cardiovascular testing appropriateness criteria from the American College of Cardiology, American Academy of Family Practitioners, American Heart Association and the Society for Heart Attack Prevention and Eradication suggest that all adults classified as “Intermediate Risk” should be tested for cardiovascular disease.
Although all patients would benefit from Level 1 Diagnostic testing, answering “yes” to two or more questions on the Level 1Diagnostics Pre-evaluation Questionnaire, qualifies a patient for intermediate risk for cardiovascular disease. Testing is, therefore, recommended and covered by most insurance carriers.
Intermediate Risk can be defined as:
- Males 45 years of age or older
- Females 55 years of age or older
- Younger adults having one or more of the following risk factors – family history of heart disease, diabetes, elevated LDL cholesterol, decreased HDL cholesterol, elevated blood pressure, obesity, tobacco use or history of tobacco use, sedentary lifestyle.
Level 1 Diagnostic Testing Program
The following tests are available through the Level 1 Diagnostics program and include the most technologically advanced and clinically validated tools for the detection of cardiovascular disease, even in its earliest stages. Physicians receive easy-to-read test reports with a treatment summary. An expanded explanation of each test is available on the video and on this site.
- Heart Rate Variability (HRV) Test: Assesses nervous system balance and function and the electrical system of the heart. HRV is the number one risk factor for sudden cardiac death.
- Pulse Wave Velocity (PWV) Analysis: The pulse wave is a snapshot of the cardiovascular system that evaluates arterial elasticity (arterial stiffness) as it relates to atherosclerosis.
- Sudomotor Function Test: The Sudomotor Test assesses the early presence of
sudomotor (sweat gland) dysfunction and it’s relation to glycemic control and peripheral nerve
function. The test provides information that determines a high risk of cardiovascular
disease, due to metabolic risk factors.
- CIMT Ultrasound: This technology detects the thickness of plaque buildup on the intima-media surface of the carotid artery.
- Home Sleep Test:Tests patients for Obstructive Sleep Apnea in their home. Sleep apnea is a major risk factor for cardiovascular disease.
The Level 1 Diagnostics testing protocol identifies various stages of cardiovascular disease in patients, thereby allowing specific treatment to stop and possibly reverse the progression of the disease and prevent cardiac events. The tests sometimes uncover serious disease in patients that require urgent medical attention. Doctors who use Level 1 Diagnostics are pleased to be part of a program that is a good medical decision for their patients and a good business decision for their practice.
We would be happy to discuss how Level 1 Diagnostics can help your practice and also answer any questions. Please call us at: 410-730-0436.
Dr. Steven Helschien
Level 1 Diagnostics